LOU ET AL.: 'Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers' PROC NATL ACAD SCI USA vol. 111, no. 7, 2014, pages 2482 - 7, XP055218264 (B1)

ZOU ET AL.: 'Chemoenzymatic synthesis and Fcgamma receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to Fcllla receptor' J AM CHEM SOC. vol. 133, no. 46, 2011, pages 18975 - 91, XP055061687 (B1)

US-A1- 2006 286 637 (B1)

US-A1- 2011 263 828 (B1)

US-A1- 2013 196 356 (B1)

US-A1- 2016 280 794 (B1)

US-A1- 2016 289 340 (B1)

WEI HUANG ET AL: "Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 134, no. 29, 16 July 2012 (2012-07-16), pages 12308-12318, XP055425387, US ISSN: 0002-7863, DOI: 10.1021/ja3051266 (B1)

WO-A1-2008/133857 (B1)

WO-A1-2011/074621 (B1)

WO-A1-2013/120066 (B1)

WO-A1-2014/078373 (B1)

WO-A1-2015/184009 (B1)

WO-A1-2016/114819 (B1)

WO-A2-2015/109180 (B1)

Y.-W. LOU ET AL: "Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 111, no. 7, 3 February 2014 (2014-02-03), pages 2482-2487, XP55218264, ISSN: 0027-8424, DOI: 10.1073/pnas.1400283111 (B1)

SCALLON ET AL: "Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 44, no. 7, 26 November 2006 (2006-11-26), pages 1524-1534, XP005792683, ISSN: 0161-5890, DOI: 10.1016/J.MOLIMM.2006.09.005 (B1)